Mary Okesola completed her BSc (Hons) Bioscience degree at University of Suffolk and went on to study the MSc Immunology at King’s College London.

Following this, she remained at King’s as a Research Assistant in translational tumour immunology where she worked on a preclinical Cancer Research UK project to establish pharmacodynamic markers for the use of a novel small molecule inhibitor combined with chemotherapy, for treatment of Breast Cancer.

She joined the Chiappini lab in October 2017 as a PhD student, her project aims to develop nanoscale approaches to regulate the phenotype of stem cells for the engineering of mini-livers.